SOSV

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.

Beeflow S.A. is a company that specializes in professional pollination services, focusing on the enhancement of bee health and efficiency. Founded in 2016 and headquartered in Buenos Aires, Argentina, Beeflow employs scientific techniques and organic compounds to improve the immune systems of bees, enabling them to effectively pollinate specific crops. The company has demonstrated significant success in increasing crop yields, with reported improvements ranging from 20% to 90% in various fruits such as blueberries, almonds, raspberries, and kiwifruit. Since its inception, Beeflow has expanded its operations to the United States and continues to grow its presence, particularly in Ventura County, California. The company's efforts aim to address the challenges of declining bee populations while supporting agricultural productivity.

Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Moirai Biodesign develops RNA-based therapies and diagnostics for cancer. The company develops non-invasive tests for in-vitro and in-situ diagnosis of AML using the patients blood; in-vivo diagnosis systems for surgical assistance and patient monitoring; and therapeutical drugs for treating cancer. Its pipeline includes RNA biomarker discovery, plug and play bio device design, and platform delivery system. The company was founded in 2016 and is based in Ireland.

Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.

Tensorfield Agriculture develops and manufactures advanced agricultural machinery specifically for specialty row crops. Founded in 2018 and based in San Jose, California, the company focuses on innovative solutions to address challenges in modern farming practices. Its product lineup includes collaborative robots equipped with computer vision technology, which perform selective, non-invasive weeding without the use of herbicides. By utilizing thermal micro-dosing techniques, these robots help farmers combat herbicide resistance and support the sustainable production of safe, fresh food. Tensorfield Agriculture is supported by the HAX hardware accelerator and has received investment from the global venture capital firm SOSV.

Sava is a company focused on advancing biosensing technology to enhance personal health monitoring. By providing real-time feedback on the body's molecular signature, particularly for athletes, Sava's technology allows for continuous and effortless monitoring of crucial metrics such as glucose and lactate levels. This capability enables athletes to train more effectively, predict fatigue, and optimize their dietary plans. Sava's innovative approach aims to make health information more accessible, delivering insights in a painless and affordable manner, thereby redefining how individuals interact with their health.

Mirá Biotech is a biotechnology company focused on the development of sustainable, formaldehyde-free engineered wood products. By utilizing waste materials, such as sugar cane bagasse, the company aims to create all-natural alternatives to traditional wood boards, thereby promoting a circular economy. This innovative approach not only eliminates the need for tree harvesting but also contributes to sustainable industrial practices, positioning Mirá Biotech as a leader in environmentally friendly manufacturing solutions.

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier.

Keel Labs, formerly known as AlgiKnit Inc., is a biomaterials company focused on developing sustainable materials for the textile industry. Founded in 2017 and based in New York, the company specializes in producing yarn spun from kelp and converting seaweed into fiber. By integrating scientific innovation with design, Keel Labs aims to create environmentally friendly alternatives to traditional textile materials, addressing the growing demand for sustainability in fashion and textile production.

BioLumen is a nutritional technology company that develops a patented dietary fiber technology platform that reduces the negative effect of a diet heavy in processed foods. BioLumen's technology is composed of insoluble dietary fiber matrix covered with a blend of food ingredients created from the latest drug delivery system research. The company's product, a nutraceutical, focuses on high risk individuals with prediabetes to help manage blood sugar levels, protect their liver from excess sugar and feed their gut microbiome, delivering health benefits. BioLumen was founded on 2018 and is headquartered in San Francisco, California.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Alternative Plants is a biotech start-up that establishes plant stem cell cultures for effective, consistent and sustainable production of cosmetic active ingredients. Our focus is on medicinal plants that are difficult to grow, are rare or even endangered, so our plant stem cell culture technology is the only way to access the valuable substances that they produce. Our current focus is on cosmetic active ingredients market. Our clients are cosmetic manufacturers that use our plant stem cell derived active substances as key active ingredients in their products. In the same time we clearly see that with our technology we can later expand to other markets as functional foods, medical devices and pharma as well.

Derived from exotic plants, protein sweeteners are rare compounds that provide an amazing taste without the calories.

Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.

Aksense is an innovative company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. Its flagship product is the first portable rapid infection diagnostic biosensor designed to improve healthcare quality and safety. By facilitating early detection and treatment of infections, Aksense's technology aims to enhance antibiotic prescribing practices and reduce the spread of infections. This approach not only improves patient outcomes but also supports public health initiatives by allowing users to recover faster through cost-effective molecular testing solutions.

Voyage Foods has made sustainable and scalable alternatives to foods that have current obstacles –environmental, social, and health alike. Our breakthrough technology provides endless opportunities to make delicious, nearly identical, versions of beloved foods, without compromising individual health or our planet. We replicated the world’s favorite foods so that we can all enjoy them, forever.

Planetarians is focused on developing innovative ingredient technology systems to create affordable and healthy plant-based proteins. The company aims to address the growing demand for alternative meats, projected to rise from 2% to 23% of consumption, by utilizing animal feed sources such as sunflower, corn DDGS, and pulses. Their approach skips traditional protein isolation methods, employing a unique process that combines solid-state fermentation and wet extrusion. This method not only enhances the protein quality and umami taste of their products but also reduces costs compared to conventional meat alternatives. Additionally, Planetarians utilizes by-products from vegetable oil extraction and beer fermentation, creating carbon-negative meat alternatives that can fortify various food products with natural protein and fiber.

ClimateCrop technologies allow plants to store more carbon and energy, resulting in increased yields in biomass or fruit states. Founded in 2021 and is based in Ness Ziona.

AnimalBiome focuses on improving the gut health of dogs and cats in the United States that suffer from chronic digestive disorders. The company offers microbiome-based supplements and non-invasive diagnostic tools designed to identify imbalances in the gut microbiome. Utilizing deoxyribonucleic acid sequencing, AnimalBiome's diagnostic services assess the balance of gut bacteria, allowing pet owners to gain insights into their pets' gut health. This information enables tailored supplementation aimed at restoring gut balance, ultimately promoting a healthier and happier life for pets.

UPSIDE Foods, formerly known as Memphis Meats, is a company headquartered in San Francisco, California, that specializes in producing cultured meat directly from animal cells. Founded in 2015 by Uma Valeti and Nicholas Genovese, the company focuses on developing products such as hot dogs, sausages, burgers, and meatballs without the need to raise and slaughter animals. This innovative approach to meat production requires significantly less caloric input, water, land, and energy compared to traditional methods, while also aiming to provide consumers with cleaner meat products that are free from harmful chemicals.

Unicorn Biotechnologies is developing a fully automated manufacturing platform to enable cellular agriculture producers to seamlessly scale products from the lab bench to supermarket shelves. Our full stack platform combines hardware, software and analytics to completely automate cellular agriculture manufacturing, reducing costs and increasing product quality. By providing a clear path to scale cellular agriculture from grams to tons, we will improve human and planetary health and drive the transition to animal free agriculture.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

OzoneBio is a cleantech company that focuses on lignocellulosic waste-derived bio-plastics production. In its workflow, they utilize the unique technology of dead cell fermentation («Zombie cells») that allows them to convert challenging/toxic feedstocks into high-value products and avoid significant expenses and complications related to live-cell fermentation. OzoneBio was founded in 2021 and is headquartered in Toronto, Canada.

Innatrix is an agricultural biotechnology company focused on developing innovative biological and chemical products aimed at controlling challenging crop diseases, pests, and weeds. Utilizing patented protein evolution technology, the company has created a peptide and RNA interference (RNAi) delivery platform that offers eco-friendly alternatives for crop protection. Innatrix's proprietary automated platform allows for advanced protein engineering through continuous laboratory evolution and other methods, such as phage display. This technology enhances researchers' capabilities in control, reporting, recording, simulation, and remote access, positioning Innatrix as a leader in sustainable agricultural solutions.

Innatrix is an agricultural biotechnology company focused on developing innovative biological and chemical products aimed at controlling challenging crop diseases, pests, and weeds. Utilizing patented protein evolution technology, the company has created a peptide and RNA interference (RNAi) delivery platform that offers eco-friendly alternatives for crop protection. Innatrix's proprietary automated platform allows for advanced protein engineering through continuous laboratory evolution and other methods, such as phage display. This technology enhances researchers' capabilities in control, reporting, recording, simulation, and remote access, positioning Innatrix as a leader in sustainable agricultural solutions.

PluriCell wants to positively impact the lives of millions of patients suffering from chronic heart failure condition by injecting healthy bona fide lab-made human heart cells in their failing heart, improve its function and, ultimately, the clinical outcome of the patients. Our tech enables us not only tackle heart diseases, but potentially, many chronic disorders currenly untractable.

Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Stämm Biotech, founded in 2014 and based in San Francisco, California, specializes in innovative biomanufacturing solutions for the life sciences sector. The company has developed a novel bioproduction system that integrates microfluidics, electroporation, and robotics to address the challenges of scaling in the biotech industry. Stämm's flagship product, the Bioprocessor, is an all-in-one, plug-and-play desktop unit that significantly enhances productivity, being at least 70 times more efficient than conventional bioreactors. Additionally, Stämm offers a suite of products including an automated continuous batch system for microbial growth, tools for tracking biological variations, and systems for monitoring microorganisms to convert data into actionable insights. This technological advancement positions Stämm to unlock a substantial market opportunity in biomanufacturing over the next decade.

QuantumCyte, Inc. is a biotechnology company based in Sunnyvale, California, founded in 2014. It specializes in developing a cell analysis system designed to enhance drug efficacy predictions and advance cancer research. By analyzing large numbers of cells, QuantumCyte aims to deepen the understanding of immune system and cancer biology. The company utilizes artificial intelligence in its pathology technology platform to provide precise cellular data, facilitating single-cell analysis for healthcare providers. Its team comprises experts from various fields, including biology, high technology, and diagnostics, with backgrounds in esteemed organizations such as Stanford and Genentech. QuantumCyte has established strong collaborations with specialists in cancer and genomic sequencing to meet fundamental research needs and ensure the scalability of its products.

Avisa Myko Inc. is a biotechnology company based in San Francisco, California, that specializes in the production of natural soluble melanin through precision fermentation technology. This innovative approach allows the company to manufacture melanin at scale and at an affordable cost, ensuring high purity and ease of application across various industries. Avisa Myko's melanin serves multiple purposes, including protection against ionizing radiation and electricity generation, and is utilized in cosmetics, biomedicine, organic semiconductors, biosensors, and textiles. The company is also developing a prototype sunscreen that leverages its melanin as an ultraviolet blocker without relying on conventional chemical or mineral filters. Through its patented technology, Avisa Myko aims to improve human health and environmental sustainability by integrating melanin into products such as latex, fabrics, and laminated materials.

NovoNutrients is focused on converting industrial waste carbon dioxide emissions into high-value protein ingredients for food and animal feed. The company has developed a fermentation platform that utilizes proprietary microbes and advanced gas fermentation systems to transform CO2, along with hydrogen and oxygen, into complete and safe single-cell protein. This innovative approach not only provides sustainable protein sources to support a growing population but also plays a role in combating climate change through carbon capture and utilization. By addressing both food security and environmental sustainability, NovoNutrients aims to meet the increasing demand for alternative protein solutions.

At NAT4Bio, we develop naturally-sourced coatings that protect produce from spoilage and decay. By leveraging microbial fermentation of selected fungi & bacteria and through carefully designed downstream processes, we obtain cell-free compounds, meaning we use microbes' active principles without the microbes themselves. Our first product is a natural and edible coating for fresh lemons that could potentially replace the combination of waxes and chemical fungicides. We are also prototyping formulations for blueberries and avocados, and we aim to expand our portfolio to address the needs of every fruit class.

ArgenTAG specializes in developing synthetic DNA barcoding technology aimed at enhancing the capabilities of long-read sequencing applications in genomics. By addressing the limitations associated with reduced multiplexing capacity and sequencing throughput, ArgenTAG enables the simultaneous analysis of thousands of samples. The company integrates advanced micro-fabrication techniques with next-generation DNA sequencing and molecular biology, leveraging reengineered error correction technologies initially derived from digital communications. This innovative approach facilitates the decentralization of genome sequencing, allowing medical professionals to effectively analyze antibodies and perform single-cell sequencing, thus advancing the field of personalized medicine.

At NAT4Bio, we develop naturally-sourced coatings that protect produce from spoilage and decay. By leveraging microbial fermentation of selected fungi & bacteria and through carefully designed downstream processes, we obtain cell-free compounds, meaning we use microbes' active principles without the microbes themselves. Our first product is a natural and edible coating for fresh lemons that could potentially replace the combination of waxes and chemical fungicides. We are also prototyping formulations for blueberries and avocados, and we aim to expand our portfolio to address the needs of every fruit class.

ArgenTAG specializes in developing synthetic DNA barcoding technology aimed at enhancing the capabilities of long-read sequencing applications in genomics. By addressing the limitations associated with reduced multiplexing capacity and sequencing throughput, ArgenTAG enables the simultaneous analysis of thousands of samples. The company integrates advanced micro-fabrication techniques with next-generation DNA sequencing and molecular biology, leveraging reengineered error correction technologies initially derived from digital communications. This innovative approach facilitates the decentralization of genome sequencing, allowing medical professionals to effectively analyze antibodies and perform single-cell sequencing, thus advancing the field of personalized medicine.

Sóliome is a biotechnology company founded in 2021 and based in San Francisco, California. The company specializes in developing protein-based sunscreens designed to be safe for both the skin and the environment. These innovative products aim to reduce inflammation and skin damage caused by traditional sunscreens, which often contain harmful xenobiotic ingredients that can absorb into the skin and contribute to ecological harm. Sóliome's approach allows customers to protect their skin from harmful rays without the adverse effects associated with conventional sunscreen formulations.

Sóliome is a biotechnology company founded in 2021 and based in San Francisco, California. The company specializes in developing protein-based sunscreens designed to be safe for both the skin and the environment. These innovative products aim to reduce inflammation and skin damage caused by traditional sunscreens, which often contain harmful xenobiotic ingredients that can absorb into the skin and contribute to ecological harm. Sóliome's approach allows customers to protect their skin from harmful rays without the adverse effects associated with conventional sunscreen formulations.

Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.

Ceragen is a biotechnology company based in Kitchener, Ontario, focused on enhancing agricultural productivity through plant microbiome engineering. The company specializes in precision microbiome engineering, offering inoculant products specifically designed for controlled environment agriculture. These products aim to provide farmers with natural solutions that enhance crop yields, allowing them to grow more food in smaller spaces. By improving plants' resilience to environmental stressors, Ceragen's innovations support sustainable farming practices and contribute to the efficient use of land resources, addressing the growing need to feed the global population.

Hexafly is a biotechnology company based in Kells, Ireland, specializing in the sustainable farming of insects to produce materials for various industries, including aquaculture, plant nutrition, and pharmaceuticals. Founded in 2016, the company utilizes Black Soldier Fly larvae to convert food waste into valuable products such as insect oil, protein meals for fish feed, frass for plant nutrition, and chitin, which is used in medicines, cosmetics, and as a food additive. By focusing on a circular economy approach, Hexafly aims to provide sustainable solutions that benefit farmers and contribute to more efficient food systems for animals and plants. The company's products are available for purchase online.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Tômtex is a developer of sustainable, bio-based materials that aim to reduce environmental impacts by utilizing food waste. The company specializes in creating alternatives to faux and animal leather, using natural biodegradable sources such as shellfish waste, mushrooms, and coffee grounds. By providing these innovative materials, Tômtex enables businesses to lower their greenhouse gas emissions and minimize their carbon footprint, contributing to a more sustainable future. The focus on 100% naturally bio-based products aligns with the growing demand for eco-friendly solutions in various industries.

VemiCo is a biotechnology company focused on extending healthy living by addressing the aging process. It utilizes artificial intelligence and synthetic biology to identify and develop promising molecules derived from gut microbial DNA. This innovative approach allows medical professionals to leverage the benefits of microbiomes, promoting gut health and enhancing overall well-being.

Valanx Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company focuses on creating SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents to produce antibody-drug conjugates for cancer treatment. This technology also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Valanx Biotech offers bioanalytics and mass spectrometry services to meet specific client needs, enhancing the efficiency and effectiveness of protein-drug conjugate development.

Circularis Biotechnologies, Inc. is a biotechnology company established in 2014 and based in California. The company focuses on developing innovative methods to regulate gene expression, aiming to enhance the production yields of biotherapeutics. Circularis offers a range of products, including RACRE Variant Libraries, hCMV Variant Library, and T7 Variant Library, as well as services such as RACRE Enhancement, RACRE Discovery, RACRE Technology Access Program, and Ribozyme Analysis of Cis-Regulatory Elements. By improving the targeting of gene therapy and optimizing gene expression in under-researched organisms, Circularis seeks to advance the fields of gene therapy, biomanufacturing, and synthetic biology, ultimately benefiting medical practitioners and enhancing therapeutic outcomes.

Solving gout using engineered probiotics

ClimateCrop technologies allow plants to store more carbon and energy, resulting in increased yields in biomass or fruit states. Founded in 2021 and is based in Ness Ziona.

ClimateCrop technologies allow plants to store more carbon and energy, resulting in increased yields in biomass or fruit states. Founded in 2021 and is based in Ness Ziona.

Veloz Bio is a biotechnology company established in 2021 and located in Monterrey, Nuevo León. The company specializes in molecular farming to develop and manufacture sustainable and affordable animal-free and alternative proteins. By leveraging efficient plant metabolism, Veloz Bio has created a rapid protein production system that enables scalable growth of new proteins. This innovation allows biotech firms to gain expertise in essential areas of protein production, including supercritical fluid extraction and membrane purification. Through its focus on alternative proteins, Veloz Bio aims to contribute to a more sustainable food supply.

Veloz Bio is a biotechnology company established in 2021 and located in Monterrey, Nuevo León. The company specializes in molecular farming to develop and manufacture sustainable and affordable animal-free and alternative proteins. By leveraging efficient plant metabolism, Veloz Bio has created a rapid protein production system that enables scalable growth of new proteins. This innovation allows biotech firms to gain expertise in essential areas of protein production, including supercritical fluid extraction and membrane purification. Through its focus on alternative proteins, Veloz Bio aims to contribute to a more sustainable food supply.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on advancing precision medicine through the development of targeted therapeutics. Founded in 2016, the company utilizes a novel bioinformatics platform to identify small ribonucleic acid (sRNA) biomarkers, which are essential for uncovering disease signatures and facilitating drug discovery and repurposing. Their technology employs machine learning to achieve high accuracy in classifying patient samples, making it a valuable tool for identifying custom biomarker panels tailored to individual needs. Gatehouse Bio collaborates with leading drug developers to discover novel drug targets and develop companion diagnostics, with applications validated in areas such as cardiology, neurology, oncology, respiratory diseases, and rare diseases.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Clara Foods Co. specializes in producing animal-free proteins and ingredients for the food and beverage industry. Founded in 2014 and based in South San Francisco, California, the company utilizes advanced fermentation techniques to create functional and nutritional proteins derived from microorganisms. This innovative approach allows Clara Foods to offer a sustainable alternative to traditional animal agriculture, focusing on products such as baking ingredients, nutritional supplements, and egg white substitutes that are free from pathogens and salmonella. Their egg white products are particularly suited for baking applications, including cakes, meringues, and macarons. Clara Foods aims to transform the food industry by providing healthier and more humane protein sources.

Tidal Vision Inc. is a company based in Ferndale, Washington, that focuses on manufacturing sustainable products derived from ocean waste, such as salmon skin and discarded crab shells. Founded in 2015, Tidal Vision offers a range of innovative products, including Alaska Salmon leather items like wallets, belts, shoes, and boots. Additionally, the company produces a variety of chitin and chitosan-based products, which serve multiple purposes, such as a fining agent for clarifying beverages, water treatment solutions, and antimicrobial applications. Other offerings include Crystal Clarity, a water clarifier for pools and spas, Game Meat Protector to prevent spoilage, High Tide, a natural shellfish extract, Tidal Grow, an all-purpose plant food, and Tidal Scrub, a sponge designed to eliminate germs and odors. Through its commitment to sustainability, Tidal Vision is positioned at the intersection of biotechnology and manufacturing.

Carverr, Inc. is a biotechnology company based in Brooklyn, New York, founded in 2018. The company specializes in developing technology to enhance product authenticity and safety through innovative solutions. Its flagship offering, ABIOGEN, utilizes programmable molecules that can be integrated into various forms, such as liquids and solids, to authenticate organic and non-organic food ingredients, agrochemicals, and consumer goods. Additionally, Carverr provides CERBERUS, a solution that transforms labels into authentication tools designed to combat counterfeiting and safeguard product quality and brand identity. The CERBERUS labels incorporate multiple security layers that can be verified by various stakeholders, ensuring the authenticity of the product. Through its advancements, Carverr aims to improve supply chain integrity and support sustainable practices within the agricultural and food sectors.

Grand Bio is working to improve the efficiency with which cells create their own growth factors. The firm provides supplements that boost growth factors in the medium in which cells live and thrive.

Pyrone Systems develops biopesticides that combine biology with chemistry. The company was founded in 2021.

Pyrone Systems develops biopesticides that combine biology with chemistry. The company was founded in 2021.

Grand Bio is working to improve the efficiency with which cells create their own growth factors. The firm provides supplements that boost growth factors in the medium in which cells live and thrive.

Criam is a biotechnology company based in Braga, Portugal, founded in 2015, that focuses on developing medical devices for blood type analysis and disease detection. The company's flagship product, also named Criam, enables rapid and affordable blood test analysis, allowing users to receive immediate information about their health. This medical device can detect various diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. By positioning itself in the Point-of-Care diagnostic segment, Criam aims to empower individuals with timely health information and contribute to the global monitoring and control of diseases.

New Culture Inc. is a food and beverage company that specializes in producing cheese from protein using innovative methods. By employing microflora to create dairy proteins and dairy products, the company aims to revolutionize traditional cheese-making processes. Founded in 2018 and headquartered in San Francisco, California, New Culture is committed to developing sustainable and alternative cheese options that appeal to a growing market of health-conscious and environmentally aware consumers.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Ardra Inc. is a renewable chemicals company based in Toronto, Canada, specializing in the production of petroleum-free specialty chemicals for the personal care and cosmetics industry. Utilizing technology developed at the University of Toronto, Ardra employs model-guided metabolic engineering and synthetic biology to create biocatalysts that convert renewable resources into essential chemicals. The company's flagship product is 1,3-butanediol, a sustainable alternative to petroleum-based counterparts, which is utilized in various applications including cosmetics, food, polymers, and pharmaceuticals. With the cosmetics sector relying heavily on petroleum chemicals, valued at approximately $2.6 billion, Ardra aims to provide environmentally friendly solutions that stabilize and sustain the supply chain while reducing ecological impact.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

Prothegen is a biotechnology company that develops cutting-edge medicines for precisely regulating cell death. The company is based in Palo Alto, California.

Prothegen is a biotechnology company that develops cutting-edge medicines for precisely regulating cell death. The company is based in Palo Alto, California.

New Culture Inc. is a food and beverage company that specializes in producing cheese from protein using innovative methods. By employing microflora to create dairy proteins and dairy products, the company aims to revolutionize traditional cheese-making processes. Founded in 2018 and headquartered in San Francisco, California, New Culture is committed to developing sustainable and alternative cheese options that appeal to a growing market of health-conscious and environmentally aware consumers.

microTERRA creates sustainable protein for farmers in LATAM. Protein is the largest cost to farmers, representing 70% of their total spend. By combining hardware and biotech, microTERRA develops microalgae systems that transform wastewater into a sustainable protein and clean water. Our first customers are fish farms. We transform their wastewater into fish feed, onsite, lowering their production costs, producing protein sustainably and cleaning the water.

California Cultured is a food company based in Davis, California, that specializes in producing sustainable, lab-grown cocoa through advanced cellular agriculture techniques. Founded in 2020, the company aims to create cocoa that is less bitter and requires less sugar, enhancing the taste while promoting health benefits. By stimulating cocoa cells with common food ingredients, California Cultured ensures the growth of premium-quality cocoa without the ethical and environmental issues associated with traditional cocoa production, such as slavery and deforestation. This innovative approach allows customers to enjoy delicious cocoa products that are both sustainable and socially responsible.

Akualogix is an agrifood tech start-up that produces shrimp, whitefish, and seaweeds in high-tech five-story farming systems. The company uses advanced technologies and sustainable practices in urban, vertical aquafarms to produce fresh shrimp, fish, and umibudo. Its vertical oceans combine multi-trophic biology with advanced digital technologies in modular growing habitats efficiently stacked in a vertical tower. Akualogix was established in 2020 and is based in Singapore.

Kyomei is a company based in Oxford, England, that focuses on developing a plant-based production system aimed at creating animal proteins for the alternative meat industry. Founded in 2021, Kyomei utilizes plant cell biology to enhance the flavor of meat alternatives by scaling the production of myoglobin in plants, which contributes to the umami taste. This innovative approach not only aims to improve the sensory experience of plant-based meats but also seeks to reduce the environmental impact associated with traditional animal farming. By providing consumers with flavorful plant-based meat options, Kyomei positions itself as a key player in the growing alternative meat market.

Every day we flush precious information on our bodies down the toilet. Bisu helps people capture these data and lead healthier, happier lives. Our product is a home health lab that provides personalized advice to help you look, feel and perform at your best, through easy, accurate urine and saliva tests. We are graduates of HAX, the world's leading hardware accelerator, and have won numerous awards including Johnson & Johnson Innovation, MedTech Innovator, the Edison Awards, UK Tech Rocketship Awards and the British Business Awards. At CES 2020 we won the IHS Markit Innovation Award and were named by CNET as one of the top health-tracking devices.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Catalog Technologies Inc. is a Boston-based company that specializes in a DNA-based platform designed for digital data storage and computation. Founded in 2016, Catalog's innovative platform encodes digital information into DNA, providing a new approach to long-term data archiving. This method not only enhances data storage capacity but also offers a cost-effective solution for managing vast amounts of information. By integrating advanced synthetic biology technologies, Catalog aims to revolutionize the way digital data is archived and processed, making DNA a viable medium for future data storage needs.

New Age Meats is a biotechnology company based in San Francisco, California, founded in 2017. The company specializes in producing cultivated meat using an automated, data-driven platform and advanced stem cell technology. By growing meat from animal cells rather than relying on traditional animal slaughter, New Age Meats aims to create healthier and more sustainable meat alternatives.

Indee Labs is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacture of gene-modified cell therapies such as chimeric antigen receptor T cells. The technology is being developed with the help of the Australian National Fabrication Facility. We are alumni of NSW Health, IndieBio, Y Combinator and MBC Biolabs (née QB3@953). We are opening up an office in Sydney and have lab space at Bonneville Labs in Berkeley.

PunaBio is a Buenos Aires-based company that develops biological products aimed at enhancing agricultural productivity through environmentally friendly methods. By utilizing extremophile microorganisms, PunaBio focuses on improving crop nutrition, which contributes to increased yields and better crop quality. Their products are designed to enable farmers to cultivate crops on degraded soils and restore and enrich agricultural land sustainably. This approach not only helps improve farmers' productivity but also promotes sustainable agricultural practices.

Plantruption builds a brand of sustainability to develop products using seaweed and microalgae. The company is on a mission to create the first plant-based seafood. It researches and collaborates with universities and food technologists to provides Plant-based seafood that’s close in taste and texture to the real deal. Plant-based seafood provides a host of environmental benefits, including alleviating pressures on rapidly depleting fisheries, providing relief to fragile ocean ecosystems, reducing the impact of fishing nets on the ocean plastic problem, and reducing production emissions. The company was founded in 2019 in Dublin, Dublin.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.

Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Karma Biotechnologies, Inc. develops therapies for autoimmune diseases. It offers Xavines, a therapeutic to treat autoimmunity, allergies, and food sensitivities. Karma Biotechnologies, Inc. was incorporated in 2019 and is based in Los Angeles, California.

Helex uses its own genomics data, bioinformatics, and intelligent data-driven platform to create, verify, and distribute therapy-specific gRNAs. Founded in 2021 and is based in New York.

Helex uses its own genomics data, bioinformatics, and intelligent data-driven platform to create, verify, and distribute therapy-specific gRNAs. Founded in 2021 and is based in New York.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Kutanios is a biotechnology firm focused on creating new compounds for anti-aging, sun care, anti-acne, and skin cleaning items. Headwuartered in London.

Kutanios is a biotechnology firm focused on creating new compounds for anti-aging, sun care, anti-acne, and skin cleaning items. Headwuartered in London.

Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.